Nomic is developing the world’s highest throughput proteomic platform.
Using DNA nanotechnology, spectral multiplexing, and automation, Nomic's nELISA platform transforms the traditional sandwich immunoassay into a massively multiplexed protein profiling tool without compromising throughput, cost, or fidelity.
- Milad Dagher, PhD
- Jeff Munzar, PhD
- Arya Tavakoli
- We are now providing our platform to the JUMP Cell Painting consortium, led by @DrAnneCarpenter at @broadinstitute.… https://t.co/Ge9qRBFKPr
- We are thrilled to announce our $17M Series A round led by @Lux_Capital! We are building the world’s highest throug… https://t.co/uLwcfFxAeJ
- We’re excited to share nplex biosciences’s new brand: Nomic Bio! As Nomic we’re advancing our goal to improve human… https://t.co/wu4YacFMAz